Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quality of life of 1276 elderly patients with prostate cancer, starting treatment with a gonadotropin-releasing hormone agonist: results of a French observational study.
Lebret T, Culine S, Davin JL, Hennequin C, Mignard JP, Moreau JL, Rossi D, Zerbib M, Mahmoudi A, Latorzeff I. Lebret T, et al. Among authors: davin jl. Aging Male. 2014 Jun;17(2):87-93. doi: 10.3109/13685538.2014.891013. Epub 2014 Feb 27. Aging Male. 2014. PMID: 24576298 Free article. Clinical Trial.
[First line indications for hormonal therapy in prostate cancer].
Boccon-Gibod L, Richaud P, Coloby P, Coulange C, Culine S, Davin JL, Soulié M, Zerbib M. Boccon-Gibod L, et al. Among authors: davin jl. Prog Urol. 2010 Feb;20(2):109-15. doi: 10.1016/j.purol.2009.11.001. Epub 2009 Dec 22. Prog Urol. 2010. PMID: 20142051 French.
[New perspectives in prostate cancer management].
Boccon-Gibod L, Davin JL, Coulange C, Culine S, Coloby P, Soulié M, Zerbib M, Richaud P. Boccon-Gibod L, et al. Among authors: davin jl. Prog Urol. 2010 Jul;20(7):491-7. doi: 10.1016/j.purol.2010.04.009. Epub 2010 Jul 1. Prog Urol. 2010. PMID: 20656270 French.
[The prostate, symbol of male vulnerability: an AFU-IPSOS quality survey].
Bardon Y, Chartier-Kastler E, Moreau JL, Davin JL, Mignard JP, Coulange C; Conseil d'Administraton de l'Association Française d'Urologie. Bardon Y, et al. Among authors: davin jl. Prog Urol. 2006 Jun;16(3):324-7. Prog Urol. 2006. PMID: 16821345 French. No abstract available.
Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial.
Fizazi K, Faivre L, Lesaunier F, Delva R, Gravis G, Rolland F, Priou F, Ferrero JM, Houede N, Mourey L, Theodore C, Krakowski I, Berdah JF, Baciuchka M, Laguerre B, Fléchon A, Ravaud A, Cojean-Zelek I, Oudard S, Labourey JL, Chinet-Charrot P, Legouffe E, Lagrange JL, Linassier C, Deplanque G, Beuzeboc P, Davin JL, Martin AL, Habibian M, Laplanche A, Culine S. Fizazi K, et al. Among authors: davin jl. Lancet Oncol. 2015 Jul;16(7):787-94. doi: 10.1016/S1470-2045(15)00011-X. Epub 2015 May 28. Lancet Oncol. 2015. PMID: 26028518 Clinical Trial.
A phase III trial of docetaxel-estramustine in high-risk localised prostate cancer: a planned analysis of response, toxicity and quality of life in the GETUG 12 trial.
Fizazi K, Lesaunier F, Delva R, Gravis G, Rolland F, Priou F, Ferrero JM, Houedé N, Mourey L, Theodore C, Krakowski I, Berdah JF, Baciuchka M, Laguerre B, Fléchon A, Ravaud A, Cojean-Zelek I, Oudard S, Labourey JL, Lagrange JL, Chinet-Charrot P, Linassier C, Deplanque G, Beuzeboc P, Geneve J, Davin JL, Tournay E, Culine S. Fizazi K, et al. Among authors: davin jl. Eur J Cancer. 2012 Jan;48(2):209-17. doi: 10.1016/j.ejca.2011.10.015. Epub 2011 Nov 24. Eur J Cancer. 2012. PMID: 22119204 Clinical Trial.
103 results